Immunitum

**Immunitum** is an orally administered dietary supplement developed by Actigenomics and positioned to support immune status and reduce the frequency, duration, and intensity of infectious episodes. It was evaluated in a randomized, double-blind, placebo-controlled study in Rwanda among children aged 12–59 months with moderate malnutrition, including assessment of recurrent upper respiratory, bronchopulmonary, gastrointestinal, and malaria-related infectious episodes. Its specific active composition, molecular targets, and mechanism of action have not been publicly disclosed in the identified sources. ([epistemonikos.org](https://www.epistemonikos.org/en/documents/ba892fdff39370de41f7c62b5773bc12791e0fa8))

Brand names

Immunitum